Summary
Since 1967, results from well controlled long term studies have provided convincing evidence of the benefit of antihypertensive therapy in middle-aged patients. However, many physicians have hesitated to apply these findings to patients over 60 years of age. Recently, the results of several prospective randomised long term trials investigating the treatment of hypertension in elderly patients have been published.
An analysis of the results of 5 major trials shows that antihypertensive treatment reduces overall mortality by 20%, cardiovascular mortality by 33%, the incidence of fatal and nonfatal cerebrovascular events by 40%, and complications as a result of coronary heart disease (i.e. fatal and nonfatal myocardial infarction and sudden cardiac death) by 15%. On the basis of trials undertaken in elderly patients with either high systolic and diastolic blood pressure or isolated systolic hypertension, antihypertensive therapy was more beneficial, in absolute terms, in elderly patients than in middle-aged patients with mild hypertension.
Treatment was withdrawn as a result of adverse effects in about 2% of middle-aged and elderly hypertensive patients per year.
Therefore, it is clear that elderly hypertensive patients should be treated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1: 1349–1354, 1985
Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. New England Journal of Medicine 327: 227–233, 1992
Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. British Medical Journal 293: 1145–1151, 1986
Dahlöf B, Lindholm LH, Hansson L, Schemen B, Ekbom T, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 338: 1281–1285, 1991
Echt DE, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. New England Journal of Medicine 324: 781–788, 1991
Helgeland A. Treatment of mild hypertension. A five year controlled drug trial. The Oslo study. American Journal of Medicine 69: 725–732, 1980
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. Journal of the American Medical Association 242: 2572–2577, 1979a
Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Journal of the American Medical Association 242: 2562–2571, 1979b
Keil U, Remmers A, Chambless L, Hense HW, Stieber J, et al. Epidemiologie des Bluthochdruckes — Häufigkeit, Verteilung, Bekanntheitsund Behandlungsgrad der Hypertonie in der Hansestadt Lübeck. Ergebnisse der Lübecker Blutdruckstudie und Vergleich mit Daten der Münchener Blutdruckstudie. Münchener Medizinische Wochenschrift 128: 424–429, 1986
Kuramoto K, Matsushita S, Kuwajima I, Murakami M. Prospective study on the treatment of mild hypertension in the aged. Japanese Heart Journal 22: 15–85, 1981
Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1: 1261–1267, 1980
Management Committee. Treatment of mild hypertension in the elderly. Medical Journal of Australia 2: 398–402, 1981
McFate Smith W. Treatment of mild hypertension. Results of a ten-year intervention trial. U.S. Public Health Service Hospitals Cooperative Study Group. Circulation Research 40 (Suppl. 1): 98–105, 1977
Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. British Medical Journal 291: 97–104, 1985
MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. British Medical Journal 304: 405–411, 1992
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 265: 3255–3264, 1991
Thijs L, Fagard R, Lijnen P, Staessen J, van Hoof R, et al. A meta-analysis of outcome trials in elderly hypertensives. Journal of Hypertension 10: 1103–1109, 1992
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. Journal of the American Medical Association 202: 116–121, 1967
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. Journal of the American Medical Association 213: 1143–1152, 1970
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 45: 991–1004, 1972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holzgreve, H., Middeke, M. Treatment of Hypertension in the Elderly. Drugs 46 (Suppl 2), 24–31 (1993). https://doi.org/10.2165/00003495-199300462-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300462-00006